The "Risk" in Pediatric Low-Grade Glioma
- PMID: 32289265
- DOI: 10.1016/j.ccell.2020.03.020
The "Risk" in Pediatric Low-Grade Glioma
Abstract
In this issue of Cancer Cell, Ryall et al. report on the largest clinically and molecularly characterized cohort of pediatric low-grade gliomas (pLGGs) published to date. They provide new insight into the pLGG molecular landscape and a novel risk stratification system with the potential to revolutionize prognostication and impact treatment.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Interests P.B. reports research grants from the Novartis Institute of Biomedical Research. Patents, royalties, and other intellectual property include Compositions and Methods for Screening Pediatric Gliomas and Methods of Treatment Thereof (international application No. WO/2017/132574, PCT/US2017/015448, filed 1/27/2017).
Comment on
-
Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas.Cancer Cell. 2020 Apr 13;37(4):569-583.e5. doi: 10.1016/j.ccell.2020.03.011. Cancer Cell. 2020. PMID: 32289278 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
